Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-26-005191
Filing Date
2026-04-01
Accepted
2026-04-01 16:51:14
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 ownership.html 3  
1 FORM 3 ownership.xml 3 4877
2 POWER OF ATTORNEY dp244735_ex24.htm EX-24 8179
  Complete submission text file 0000950103-26-005191.txt   14460
Mailing Address ECKENHEIMER LANDSTRASSE 100 FRANKFURT 2M 60318
Business Address
Zuegel Martin (Reporting) CIK: 0001484988 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37891 | Film No.: 26829127

Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Issuer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)